Additionally, evidence indicates that miR-182 is a potential regulatory microRNA for BDNF, suggesting that serum BDNF and related miRNAs could serve as valuable biomarkers for diagnosing depression or as potential therapeutic targets [21]. The gene discussed is BDNF; the disease is depressive symptom measurement.